Cargando…
Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants
Bacterial L-asparaginases have been used as anti-cancer drugs for over 4 decades though presenting, along with their therapeutic efficacy, several side effects due to their bacterial origin and, seemingly, to their secondary glutaminase activity. Helicobacter pylori type II L-asparaginase possesses...
Autores principales: | Maggi, Maristella, Chiarelli, Laurent R., Valentini, Giovanna, Scotti, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321988/ https://www.ncbi.nlm.nih.gov/pubmed/25664771 http://dx.doi.org/10.1371/journal.pone.0117025 |
Ejemplares similares
-
Tackling Critical Catalytic Residues in Helicobacter pylori
l-Asparaginase
por: Maggi, Maristella, et al.
Publicado: (2015) -
Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase
por: Scotti, Claudia, et al.
Publicado: (2010) -
Correction: Cell-Cycle Inhibition by Helicobacter pylori L-Asparaginase
por: Scotti, Claudia, et al.
Publicado: (2012) -
Structural Aspects of E. coli Type II Asparaginase in Complex with Its Secondary Product L-Glutamate
por: Maggi, Maristella, et al.
Publicado: (2022) -
Revealing Escherichia coli type II l-asparaginase active site flexible loop in its open, ligand-free conformation
por: Maggi, Maristella, et al.
Publicado: (2021)